Nxera Pharma Notes Successful Development Progress of Partnered Schizophrenia Candidate NBI-1117568
16 avr. 2024 02h30 HE
|
Nxera Pharma
NBI-1117568 is an oral, selective muscarinic M4 receptor agonist advancing through Phase 2 clinical development under a multi-program collaboration with Neurocrine BiosciencesSuccessful completion of...
Athira Pharma Doses First Subject in Phase 1 Clinical Trial of HGF/MET Positive Modulator, ATH-1020, an Orally Available Small Molecule for Neuropsychiatric Conditions
04 avr. 2022 07h00 HE
|
Athira Pharma, Inc.
BOTHELL, Wash., April 04, 2022 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal...
Praxis Precision Medicines to Present at Citi’s 16th Annual BioPharma Virtual Conference
01 sept. 2021 09h00 HE
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Six Outstanding Mental Health Researchers Honored by the Brain & Behavior Research Foundation
04 août 2021 10h00 HE
|
Brain & Behavior Research Foundation
New York, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) has announced the winners of its 2021 Klerman and Freedman Prizes, which recognize exceptional...
Praxis Precision Medicines to Present at Upcoming Investor Conferences
06 juil. 2021 09h00 HE
|
Praxis Precision Medicines, Inc.
CAMBRIDGE, Mass., July 06, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Dr. Stephen I. Kramer Appointed to American Health Council’s Board of Physicians
06 sept. 2017 08h00 HE
|
American Health Council
NEW YORK, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Dr. Stephen I. Kramer, Professor Emeritus at Wake Forest Baptist Health Sciences and Field Representative/Physician Surveyor at The Joint Commission, has...
American Health Council Names Michael Irwin, M.D. to Physician Board
06 déc. 2016 13h00 HE
|
American Health Council
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- Dr. Michael Irwin, Director and Cousins Distinguished Professor of Psychiatry at UCLA Medical Center, has been selected to join the Physician Board...
American Health Council Names Neil Kaye, MD, DFAPA to Physician Board
29 nov. 2016 10h00 HE
|
American Health Council
NEW YORK, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Dr. Neil Kaye, Forensic Psychiatrist, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and...